Menu

Blog

Apr 16, 2019

Extending Human Longevity With Regenerative Medicine

Posted by in categories: biotech/medical, life extension

Understandably, the FDA raised concerns about the practice of parabiosis because to date, there is a marked lack of clinical data to support the treatment’s effectiveness.

Elevian

On the other end of the reputability spectrum is a startup called Elevian, spun out of Harvard University. Elevian is approaching longevity with a careful, scientifically validated strategy. (Full Disclosure: I am both an advisor to and investor in Elevian.)

Read more

Comments are closed.